Showing 15 posts of 31 posts found.

Hospira in US-wide recall of product due to contamination

January 25, 2017
Medical Communications Contamination, Hospira, Pfizer

Hospira, a company owned by Pfizer, has been forced to recall a batch of injectable drugs due to “the presence …

ICU Medical to acquire Pfizer’s global infusion therapy business in $1 billion deal

October 6, 2016
Medical Communications Hospira, ICU medical, Pfizer, acquisition, infusion

The $1 billion deal that will take place as ICU Medical Inc. take over Pfizer’s Hospira Infusion Systems will be …

Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016
Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …


Pfizer completes $15 billion Hospira acquisition

September 4, 2015
Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions

Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …

Hospira image

Data supports switching to Hospira biosimilar for RA

June 10, 2015
Research and Development, Sales and Marketing EULAR, Hospira, Janssen, RA, brett wells, celltrion, inflectra, rome

Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …

Napp image

Napp launches biosimilar in UK

February 25, 2015
Research and Development, Sales and Marketing Hospira, Napp, Remicade, anti-TNF biologic, biosimilar, infliximab, remsima

Napp Pharmaceuticals has launched its own biosimilar version of an anti-TNF biologic in Europe paving the way for patient access …

Propofol image

Hospira recalls Propofol drug again

February 10, 2015
Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol

Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …

Hospira image

Pfizer to buy Hospira for $17 billion

February 5, 2015
Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …

Hospira image

Hospira closing US manufacturing plant

January 20, 2015
Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing

US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …

Hospira image

Hospira recalls drug due to storage hiccup

October 13, 2014
Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly

Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …


Herceptin faces UK competition within months

April 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer

Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …

Manufacturing image

Pharma manufacturing news in brief

February 17, 2014
Manufacturing and Production Advaxis, Alexion, Berkshire Sterile Manufacturing, Catalent, Hospira, Shire

Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …

Hospira image

Hospira’s Inflectra approved in Europe

September 10, 2013
Research and Development, Sales and Marketing Hospira, Janssen, Remicade, biosimilars, inflectra

Hospira has been the first firm to meet the European Commission’s approval for a biosimilar monoclonal antibody therapy with its …

Remicade image

Remicade copies set for European entry

July 1, 2013
Sales and Marketing CHMP, Hospira, Janssen, Remicade, arthritis, biosimilar

Janssen’s Remicade could soon come under generic pressure after a landmark recommendation by the CHMP. South Korean biotech Celltrion and …


Hospira Reappoints chief scientific officer

May 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …

Latest content